No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma.
Knight TE, Ahn KW, Hebert KM, Atshan R, Wall DA, Chiengthong K, Lund TC, Prestidge T, Rangarajan HG, Dvorak CC, Auletta JJ, Kent M, Hashem H, Talano JA, Rotz SJ, Fraint E, Myers KC, Leung W, Sharma A, Bhatt NS, Driscoll TA, Yu LC, Schultz KR, Qayed M, Broglie L, Eapen M, Yanik GA.
Knight TE, et al. Among authors: eapen m.
Bone Marrow Transplant. 2023 Dec;58(12):1390-1393. doi: 10.1038/s41409-023-02092-3. Epub 2023 Sep 4.
Bone Marrow Transplant. 2023.
PMID: 37666957
Free PMC article.
No abstract available.